
51 - 200 employés
Fondée en 2005
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Capricor Therapeutics, Inc. est une entreprise de biotechnologie en phase clinique développant des thérapies à base de cellules et d'exosomes, concentrée sur la médecine de précision pour la dystrophie musculaire de Duchenne et d'autres maladies graves. La société fait progresser les cellules cardiosphères allogéniques (CDCs) et les plateformes d'exosomes à travers un pipeline multi-étapes, incluant la thérapie cellulaire expérimentale (deramiocel) et des approches pour le chargement d'oligonucléotides thérapeutiques dans les exosomes. Capricor met l'accent sur le développement axé sur le patient, la recherche translationnelle et les partenariats stratégiques pour apporter des médicaments biologiques novateurs aux patients.
🕒 il y a 3 mois
🇺🇸 États-Unis – Télétravail
💵 $200 000 - $250 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
👻 Score fantôme 11%
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

51 - 200 employés
Fondée en 2005
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Capricor Therapeutics, Inc. est une entreprise de biotechnologie en phase clinique développant des thérapies à base de cellules et d'exosomes, concentrée sur la médecine de précision pour la dystrophie musculaire de Duchenne et d'autres maladies graves. La société fait progresser les cellules cardiosphères allogéniques (CDCs) et les plateformes d'exosomes à travers un pipeline multi-étapes, incluant la thérapie cellulaire expérimentale (deramiocel) et des approches pour le chargement d'oligonucléotides thérapeutiques dans les exosomes. Capricor met l'accent sur le développement axé sur le patient, la recherche translationnelle et les partenariats stratégiques pour apporter des médicaments biologiques novateurs aux patients.
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.**• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.**• Support advisory boards, scientific symposia, and KOL-led research initiatives.**• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.**• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.**• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.**• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.**• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.**• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.**• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.**• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.**• Perform other duties as may be assigned from time to time.
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).**• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.**• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.**• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.**• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.**• Self-directed execution and the ability to operate independently in a field-based environment.
• Collaborative environment for professional growth and innovation
Postuler Maintenant🕒 il y a 3 mois
Legal transactions director leading M&A, investments, and strategic partnerships for Ciena, a high-speed connectivity company. Driving deal execution, due diligence, negotiation, and post-close integration.
🇺🇸 États-Unis – Télétravail
💵 $181 000 - $269 100 / an
💰 Series C en 1995-12
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 mois
Regional Director responsible for Medical Informatics sales in the Pacific Northwest region. Achieving bookings and revenue objectives through strategic selling in a healthcare technology company.
🗣️🇺🇸🇬🇧 Anglais requis
🗣️🇪🇸 Espagnol requis
🕒 il y a 3 mois
Director of Consulting Services at Zaviant, leading delivery in data security, privacy, and risk management. Focusing on operational excellence and client satisfaction in a boutique consulting firm.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 mois
Division Contract Director overseeing DOJ's MEGA 6 automated litigation support program. Responsible for contact coordination with government and managing division operations in a remote work setting.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 mois
Senior manager coordinating DOJ-Wide Contract Director activities supporting ITC Federal's work for the U.S. Department of Justice under the anticipated MEGA 6 program.
🗣️🇺🇸🇬🇧 Anglais requis